Filter
5285
Text search:
drug
access
Featured
Recommendations
472
New Publications
1401
Language
Document type
No document type
3144
Studies & Reports
888
Guidelines
633
Manuals
236
Strategic & Response Plan
177
Fact sheets
75
Training Material
68
Situation Updates
23
Infographics
16
Resource Platforms
12
Brochures
6
Online Courses
3
App
2
Videos
1
Countries / Regions
India
285
Global
188
Kenya
166
South Africa
140
Uganda
128
Ethiopia
120
Nigeria
115
Western and Central Europe
113
Tanzania
101
Nepal
90
Sierra Leone
87
Liberia
85
Malawi
85
Africa
85
Zambia
82
Myanmar / Burma
78
Latin America and the Carribbean
74
Bangladesh
69
Ghana
67
Rwanda
67
Eastern Europe
59
Namibia
56
Ukraine
55
Asia
44
Zimbabwe
43
Philippines
43
Cambodia
36
Lesotho
36
South–East Asia Region
36
Russia
27
Congo, Democratic Republic of
26
Botswana
26
Syria
24
Senegal
23
Indonesia
23
Mozambique
23
Burkina Faso
21
Eswatini/ Swaziland
19
East and Southern Africa
19
Cameroon
16
South Sudan
16
Brazil
16
Haiti
15
Colombia
15
West and Central Africa
15
Thailand
13
Eastern Europe and Central Asia
12
USA
11
Middle East and North Africa
11
Venezuela
11
Albania
11
Tajikistan
11
Guinea
10
Pakistan
10
China
10
Georgia
10
Vietnam
10
Afghanistan
9
Germany
9
Benin
9
Moldova
8
Sudan
7
Laos
7
North Macedonia
6
Mexico
6
Sri Lanka
6
Western Pacific Region
6
Armenia
6
North America
6
Mali
5
Iraq
5
Jordan
5
Lebanon
5
Central African Republic
5
Peru
5
Somalia
4
Turkey
4
Argentina
4
El Salvador
4
Libya
4
Yemen
4
Timor Leste/ East Timor
4
Iran
4
Jamaica
4
United Kingdom
4
Côte d’Ivoire / Ivory Coast
3
Papua New Guinea
3
Honduras
3
Bolivia
3
Madagascar
3
Bhutan
3
Palestine
3
Kyrgyzstan
3
Morocco
2
Saudi Arabia
2
Chad
2
Switzerland
2
Serbia
2
Hungary
2
Guatemala
2
Nicaragua
2
Chile
2
Poland
2
Southern Africa
2
Canada
2
Uzbekistan
2
Kazakhstan
2
Gabon
2
France
2
Portugal
2
Spain
2
Belarus
2
Niger
1
Egypt
1
Gambia
1
Ireland
1
Singapore
1
Dominican Republic
1
Ecuador
1
Greece
1
Paraguay
1
Fiji
1
North Korea
1
Italy
1
Mongolia
1
Congo-Brazzaville
1
Qatar
1
Bulgaria
1
Estonia
1
Romania
1
Lithuania
1
Australia
1
Uruguay
1
Turkmenistan
1
Denmark
1
Belgium
1
Maldives
1
Tunisia
1
Norway
1
Belize
1
Costa Rica
1
Panama
1
Authors & Publishers
Publication Years
Category
Countries
2023
Clinical Guidelines
429
Public Health
247
Women & Child Health
205
Key Resources
157
Capacity Building
84
Pharmacy & Technologies
55
Annual Report MEDBOX
1
Toolboxes
HIV
705
Mental Health
486
TB
484
AMR
257
NTDs
202
COVID-19
196
Pharmacy
151
NCDs
106
Malaria
101
Caregiver
100
Ebola & Marburg
78
Planetary Health
69
Refugee
67
Disability
62
Conflict
62
Rapid Response
60
Global Health Education
59
Health Financing Toolbox
51
2.0 Rapid Response
25
Cholera
22
Polio
19
Natural Hazards
18
Zika
16
Specific Hazards
14
Social Ethics
13
The leishmaniases are a group of diseases caused by Leishmania spp., which occur in cutaneous, mucocutaneous and visceral forms. They are neglected tropical diseases (NTDs), which disproportionately affect marginalized populations who have limited access
...
Antibiotic Stewardship (AS) is a coordinated program that promotes the appropriate use of antimicrobials to improve patient outcomes, reduce microbial resistance, and decrease the spread of multi-drug resistant organisms. In clinical settings, stewa
...
6th edition, 2010. | Published in collaboration with World Health Organisation and Clinton Health Access Initiative.
Getting Contraceptives To Health Facilities: 10 Questions For Community-Based Groups To Consider
recommended
This Guide helps all the health care providers in the non- public sector to explore alternative means of access to contraceptives and skills to determine quantities required and management of stock. Health care providers include community health wor
...
The WHO South-East Asia (SEA) Region bears a high burden of tuberculosis (TB) and MDR-TB. In 2015, the Region accounted for nearly 200 000 or 35% of the global estimated new RR/MDR-TB cases eligible for treatment. Extensively drug-resis
...
The conduct of COVID-19 vaccine trials in the context of a candidate vaccine being issued with Emergency Use Designation raises challenging ethical questions, including in relation to the use of placebo controls and unblinding of trial participants in current and future COVID-19 vaccine trials. This
...
The pharmaceutical sector of any nation is responsible for providing society with quality medicines and other pharmaceutical services. According to the World Health Organization (WHO), Pharmaceuticals may constitute as much as 40% of the national health budget in developing countries, yet portions o
...
This publication seeks to describe the best treatments and practices based on the scientific evidence available at the time of writing as evaluated by the authors and may change as a result of new research. Readers need to apply this knowledge to patients in accordance with the guidelines and laws o
...
The Adult Standard Treatment Guidelines and Essential Medicines List for Hospital Level provide a platform for transparency to enable equitable access to safe, effective, and affordable treatment options at hospital level taking into consideration t
...
Journal of the International AIDS Society 2017, vol. 20:e25026
In Myanmar, men who have sex with men (MSM) experience high risk of HIV infection. However, access to HIV testing and prevention services remains a challenge among this marginalized ...
In Myanmar, men who have sex with men (MSM) experience high risk of HIV infection. However, access to HIV testing and prevention services remains a challenge among this marginalized ...
Community health workers (CHWs) enable marginalised communities, often experiencing structural poverty, to access healthcare. Trust, important in all patient–provider relationships, is difficult to build in such
communities, particularly when sti
...
Six months after its launch on 24 April, the Access to COVID-19 Tools (ACT) Accelerator has already delivered concrete results in speeding up the development of new therapeutics, diagnostics, and vaccines. Now mid-way through the scale-up phase, the
...
Guidelines for the prevention, care and treatment of persons with chronic hepatitis B infection
recommended
The recommendations in these guidelines promote the use of simple, non-invasive diagnostic tests to assess the stage of liver disease and eligibility for treatment; prioritize treatment for those with most advanced liver disease and at greatest risk of mortality; and recommend the preferred use of n
...
In May the Sixty-sixth World Health Assembly adopted resolution WHA66.12 (1) on 17 neglected tropical diseases (NTDs). Among other measures, the resolution urges Member States to:
• ensure country ownership of prevention, control, elimination and eradication programmes;
• expand and implemen
...
Antimicrobial Resistance Surveillance and Research Network | This manual describes well accepted methods to carry out drug susceptibility testing on important gram positive and gram negative clinically relevant bacteria. Methods of specimen collecti
...
Lymphatic filariasis is a neglected tropical disease that can cause permanent disability through disruption of the lymphatic system. This disease is caused by parasitic filarial worms that are transmitted by mosquitos. Mass drug administration (MDA)
...
No publication year indicated
The specific objectives of the plan are to:
- Scale up evidence-based, cost effective interventions through effective strategies within a HSS approach and provide equitable coverage with quality.
- Reduce neonatal mortality by improved home-based newborn ...
The specific objectives of the plan are to:
- Scale up evidence-based, cost effective interventions through effective strategies within a HSS approach and provide equitable coverage with quality.
- Reduce neonatal mortality by improved home-based newborn ...
BMC Family Practice201415:165, DOI: 10.1186/1471-2296-15-165
Open Access
This publication is intended for professionals training or practicing in mental health and not for the general public. The opinions
expressed are those of the authors and do not necessarily represent the views of the Editor or IACAPAP. This publication seeks to
describe the best treatments and pra
...
Time has seen management for Cystic Fibrosis (CF) advance drastically, most recently in the development of the disease-modifying triple combination therapy ivacaftor/tezacaftor/elexacaftor. There is currently limited evidence regarding both the global epidemiology of CF and
...